WILMINGTON, Del., Feb. 9 /PRNewswire/ -- The rapid increase of cost in China has broughtsome shadow to the CRO and CMO businesses there. However, DS Chemphy, Inc., a USA-based contract research and manufacturing organization that focuses on fine and pharmaceutical chemicals, continues investing in its businesses.
Dr. Shen continues: "What makes Chemphy so attractive to our customers? The answers are: high-standard EHS management, high quality products and services, proprietary technologies, high efficiency, excellent IP protection, active communication, and integrated capability from R&D to manufacture."
Since DS Chemphy acquired New Chemphy in 2007, DS Chemphy has invested over $45 million in CRO/CMO capability as well as corporate culture and management reform. New Chemphy was founded by the Chinese Academy of Sciences. DS Chemphy integrated Chinese and Western advantages, i.e. lower costs of China and high-standard quality management of the West. The successful story was reported by C&E News (Issue Sept 1, 2008, page 35).
Most senior executives of the company have overseas training or work experience. The company now employs over 1000 chemical professionals. Last year, the company built a world-class R&D center. 150 chemists, including 25 PhDs, work in the center. The labs are equipped with state-of-the-art instruments including NMR, LC-MS, GC-MS, DSC, RC1, and GPC. The company has two manufacturing sites capable of production at pilot, multi-functional, and commercial scale. The reactors cover all sizes up to 20M(3). The reactors are either made of stainless steel, or glass-lined, nickel-lined, titanium-lined, Hastelloy-lined or polytetrafluoroethylene-lined.
DS Chemphy offers quality products based on Chemphy proprietary technology platforms including cyclopropanation, fluorination, and catalytic continues process, etc.
Recently DS Chemphy launched three new products:
Cyclopentyl methyl ether -- THF alternative
ChemphySteel® -- Polymers as strong as steel
ChemphyFresh® -- Keep your fruits and vegetables fresh
Visit us at booth 117 at InformEx USA, San Francisco, CA February 16-19, 2010, or www.dschemphy.com. You may also contact Aaron Shen, President of DS Chemphy at tel: 302-351-8401, fax: 302-351-6101 or email: firstname.lastname@example.org.
SOURCE DS Chemphy, Inc.
Subscribe to our Free Newsletters!
This is a branch of telemedicine that delivers eye care via a digital medical equipment and ...
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells ...View All